Astrazeneca Pharmaceuticals Revenue, Growth & Competitor Profile

DBA ASTRAZENECA LP

Company Profile & Annual Report for Astrazeneca Pharmaceuticals

Access the complete profile.

Astrazeneca Pharmaceuticals Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	3251 Basic Chemical Manufacturing 325412 Pharmaceutical Preparation Manufacturing
Address	1800 Concord Pike Po Box 15437 Wilmington, DE 19850

Note: Revenues for privately held companies are statistical evaluations.


Astrazeneca Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Astrazeneca Pharmaceuticals's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Astrazeneca Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Astrazeneca Pharmaceuticals Annual Revenue and Growth Rate

Astrazeneca Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Astrazeneca Pharmaceuticals's revenues are gauged from an analysis of company filings.

Astrazeneca Pharmaceuticals's Income Statement (based on Industry Averages)

Astrazeneca Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Astrazeneca Pharmaceuticals is developing and marketing. Astrazeneca Pharmaceuticals doesn't have any recent trademark applications, indicating Astrazeneca Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
BCISE Pharmaceutical preparations and substances for the treatment of metabolic diseases and disorders	04/01/2015
ATHEROVIEW Spectrometers	02/12/2008
VASORISK Spectrometers	02/12/2008

See all trademarks and details in the Full Report.

Market Share of Astrazeneca Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Astrazeneca Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Astrazeneca Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ASTRAZENECA PHARMACEUTICALS	Wilmington, DE	100
BELLUS HEALTH	Wilmington, DE	1
OYSTERSHELL CONSUMER HEALTH	Wilmington, DE	0
MICREOS FOOD SAFETY USA	Wilmington, DE	0
SHANGHAI PHARMACEUTICAL USA	Wilmington, DE	0
HEPAITECH	Wilmington, DE	0

Future Competition: Astrazeneca Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Astrazeneca Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)